Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 January 2008

Tacrolimus – biotechnological prospects for a generic product

W. Gajzlerska, J. Turło, B. Gutkowska, F. Herold

Ann Transplant 2008; 13(1): 40-41 :: ID: 880205

Abstract

Background: Tacrolimus, an immunosuppressive calcineurin inhibitor, is widely used in transplantation, as well as in dermatology and invasive cardiology. This drug, first discovered as the product of Streptomyces tsukubaensis, is isolated from the whole fermentation broth of these bacteria cultivated in submerged culture strain. The aim of our research was to optimize the process of tacrolimus biosynthesis by means of submerged cultivation using liquid media containing by or waste- products of food industry. The next goal was to examine the influence of C3 effectors such as propanol, propylene glycol and propionic acid on productivity of the biosynthesis process.
Materials/Methods: The Streptomyces tsukubaensis strain (FERM BP-927) was used to investigate the relationships between the composition of the cultivation medium, the mycelial growth and tacrolimus production. Furthermore, the cultures were enriched with propanol, propylene glycol and propionic acid, used as biosynthesis precursors.
Results: The productivity of tacrolimus by the strain is proportional to the mycelial growth. The highest productivity recorded for medium composed in-part of waste products of food industry and not enriched in precursors was approximately 12 μg/mL, and thus approximates the productivity declared in Okuhara et al's US patent. The addition of the biosynthesis precursors, propanol, propylene glycol and propionic acid results in about 3-fold higher biosynthesis productivity. The highest productivity was obtained when
propylene glycol was used.
Conclusions: There is a strong correlation between the composition of the tested media and the strain productivity. Propanol, propylene glycol and propionic acid exert an inducing effect on tacrolimus biosynthesis.

Keywords: Tacrolimus, P. mirabilis, propanol

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358